NRX Pharmaceuticals NRXP
NASDAQ NRXP
$2.85 -0.07 (-2.40%)
At close: Oct 1, 2026 · 4:00 PM EDT

NRX Pharmaceuticals (NRXP) Short term Debt (2024 - 2026)

Updated

NRX Pharmaceuticals (NRXP) recorded Short term Debt of $412,000 in Q2 2026, up 9.0% from $378,000 a year earlier.

Analysis

NRX Pharmaceuticals (NRXP) Short term Debt (2024 - 2026) Analysis & Trends

At the end of FY2024, NRX Pharmaceuticals reported Short term Debt of $320,000.

  • The Q2 2026 figure is the highest quarterly Short term Debt since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 NRX Pharmaceuticals 126.02 Mn 77.61 Mn 426,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 412,000.00
Sep 30, 2025 152,000.00
Jun 30, 2025 378,000.00
Dec 31, 2024 320,000.00
Sep 30, 2024 634,000.00
Jun 30, 2024 943,000.00
API Access

NRX Pharmaceuticals Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=NRXP&period=max&api_key=YOUR_API_KEY